Breast Suite (SmartMammo)
Enhanced workflow and diagnostic accuracy in breast cancer detection
Software · Cloud SaaSCompany source
Company profile
About DeepHealth
DeepHealth is a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT). The company provides comprehensive radiology solutions that unify imaging, informatics, and artificial intelligence to transform diagnostic workflows and care delivery. At the heart of DeepHealth's portfolio is the pioneering cloud-native DeepHealth OS operating system, which connects data across clinical and operational workflows and personalizes AI-powered workspaces for everyone in the radiology continuum. DeepHealth's product portfolio spans enterprise imaging solutions including Diagnostic Suite (unified PACS workspace), Operations Suite (RIS functionality and workflow management), and TechLive (multi-modality remote scanning platform). The company also offers specialized population health solutions across multiple clinical areas: Breast Suite for mammography screening, Prostate Suite for prostate cancer detection, Chest Suite for lung nodule management, Neuro Suite for neurodegenerative assessment, and Thyroid Suite for thyroid ultrasound imaging. Following the 2026 acquisition of Paris-based Gleamer, DeepHealth became the largest provider of radiology clinical AI solutions worldwide, serving over 700 customer contracts across 44 countries. The combined portfolio supports screening, detection, interpretation, and follow-up across prevalent cancer types, neurodegenerative conditions, and musculoskeletal applications. DeepHealth's technology enables screening programs at scale, serving 300+ sites globally, and is designed to address the accelerating radiologist shortage by advancing automated exam prioritization and draft reporting capabilities.
Company description DeepHealth official website
Primary marketMedical Imaging & Radiology
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at DeepHealth?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- breast cancer
- chronic musculoskeletal conditions
- lung nodules
- musculoskeletal conditions
- neurodegenerative diseases
- neurologic conditions
- prostate cancer
- thyroid conditions
- trauma
Who it serves
- Health Systems
- Hospitals
- Imaging Centers
- Radiology Groups
Deployment & integration
Cloud Saas deployment with recorded integration context.
Geographic context
Markets44 countries worldwide · Europe · United States
Company sourceOfficial website
Company milestones
Platform expansion
March 2026: Acquired Gleamer SAS for up to €230 million, becoming largest provider of radiology clinical AI solutions worldwide. February 2026: Achieved CE Mark for TechLive and enabled AWS Marketplace deployment. Achieved FDA clearance and CE Marking for Prostate AI. CE Marking for Brain Health, Brain Age, and LumbarMR solutions. Launched Reporting Pro with AI automation. RadNet joint venture with Saint Alphonsus Health System in Boise, Idaho.
Partnerships
Recorded partners
- AWS (Amazon Web Services)
- Intermountain Medical Imaging
- RadNet (parent company)
- Trinity Health's Saint Alphonsus Health System
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Chest Suite (DeepHealth Lung)
Enhanced nodule detection, reporting and patient management
Software · Cloud SaaSCompany source
DeepHealth Brain (formerly Quantib ND and Quantib Brain)
Assess and monitor neurodegenerative changes with quantitative and reference data
Software · Cloud SaaSCompany source
DeepHealth Brain (Neuro Suite)
Assess and monitor neurodegenerative changes with AI-powered brain imaging
Software · Cloud SaaSCompany source
DeepHealth Lung (Chest Suite)
Enhanced nodule detection, reporting and patient management
Software · Cloud SaaSCompany source
DeepHealth OS
Cloud-native operating system powering DeepHealth's AI solutions
Platform · Cloud SaaSCompany source
DeepHealth Prostate (formerly Quantib Prostate)
Enhanced prostate cancer detection, compatible with leading fusion biopsy systems
Software · Cloud SaaSCompany source
DeepHealth Prostate (Prostate Suite)
Enhanced prostate cancer detection compatible with leading fusion biopsy systems
Software · Cloud SaaSCompany source
Diagnostic Suite
Unified diagnostic workspace with PACS functionality and AI orchestration
Platform · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
OMAMA-DB: the Oregon-Massachusetts Mammography Database.Journal of medical imaging (Bellingham, Wash.) · Nov 1, 2026
A Learning Accelerator Framework: Scalable Clinical Artificial Intelligence Development and Delivery.Journal of the American College of Radiology : JACR · May 1, 2026
Enhanced cervical cancer diagnosis using a novel Bayesian fusion ensemble method with explainable AI.Scientific reports · Mar 5, 2026
Prospective evaluation of artificial intelligence integration into breast cancer screening in multiple workflow settings: the GEMINI study.Nature cancer · Mar 1, 2026
Operating Point Optimization for Efficient Mammogram Triage Using Only Highly Elevated Probability scores.Clinical breast cancer · Jan 1, 2026
MRI approach to the patient with suspected dementia: artificial intelligence techniques and semi-quantitative rating scales compared.Frontiers in radiology · Jan 1, 2026
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
Saige-DxK251873 · 510k · Aug 11, 2025
Saige-Density (2.5.0)K243705 · 510k · Dec 19, 2024
Saige-Dx (3.1.0)K243688 · 510k · Dec 19, 2024
Saige-DxK241747 · 510k · Nov 18, 2024
Saige-DensityK222275 · 510k · Dec 16, 2022
Saige-DxK220105 · 510k · May 12, 2022
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
42% reduction in MR room closure hours
Within RadNet using TechLive
27% increase in access to complex procedures
Within RadNet using TechLive
Increased cancer detection rate
AI-driven breast cancer screening in landmark Nature Health Study
90%+ ARR compound annual growth rate
Gleamer 2022-2025
RadNet
Remote scanning across multi-site network to expand imaging capacity and manage workforce needs
42% reduction in MR room closure hours and 27% increase in access to complex procedures; connected more than 400 scanners
RadNet breast screening sites
Multistage AI-driven workflow for breast screening in dense breasts
Significantly improved cancer detection rate (CDR) and positive predictive value (PPV1) for women with dense and non-dense breasts across 570,000+ cases
RadNet screening mammography sites
AI-driven workflow to improve general radiologist performance
General radiologist screening mammography performance improved to the level of fellowship-trained breast imagers in >500,000 patients
Multiple centers (prostate MRI study)
Reducing workflow and read-time of prostate MRIs
14.1% reduction in radiologists' read-time, 37% reduction in overall workflow time for biopsy-recommended cases (232 hours or 6 weeks saved)
NHS England Targeted Lung Health Check Programme
Large-scale lung cancer screening program across 25+ sites
76% of detected cancers caught at earlier stages (vs 29% historically), 2,748 cancers diagnosed from 163,000 CT scans (1.7% conversion), additional 781 early-stage cancers diagnosed
Two unnamed radiology centers
Reducing workflow and read-time of prostate MRIs
14.1% reduction in radiologist read-time, 37% reduction in overall workflow time for biopsy-recommended cases (232 hours or 6 weeks saved)
UK National Lung Health Check Programme
Large-scale lung cancer screening program across 25+ sites
1.22 million invitations issued, 44% uptake, 2,748 cancers diagnosed (1.7% conversion), 781 additional early-stage cancers diagnosed, three-quarters at stage 1-2
300+ sites globally
Large-scale screening programs using DeepHealth technology to enhance accuracy and optimize radiologist expertise
Screening at scale across 300+ sites globally with enhanced accuracy
Portsmouth Hospitals University NHS Trust
Deployment of lung solution for AI-assisted lung nodule detection
Smooth deployment with seamless workflow integration
Saint Alphonsus Health System (Trinity Health)
Multi-site joint venture with RadNet in Boise, Idaho for outpatient diagnostic imaging services
Formation of joint venture through acquisition of majority equity position in Intermountain Medical Imaging, LLC
Salisbury NHS Foundation Trust
CT reporting efficiency improvement with lung solution
Radiologist doing twice as much CT reporting
Salisbury NHS Foundation Trust and University Hospitals Southampton NHS Trust
CT reporting efficiency with lung AI solution
Radiologist reporting 'twice as much CT reporting' with AI assistance
Wichita Radiology Group
Replaced legacy RIS with Operations Suite to advance operations, strengthen care coordination and deliver a more connected, patient-centered imaging experience
Advanced operations and strengthened care coordination across multi-site network
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
Kees Wesdorp
President and CEO
Kees Wesdorp
President and CEO of RadNet's Digital Health division
Andra Axente
Communications Director
Howard Berger
President and CEO
Madhu Jahagirdar
Head of Product and Platforms, Enterprise Imaging
Vickie Bedel
Senior Vice President and Chief Digital Operations Officer
Christian Allouche
Co-Founder and CEO
Andra Axente
Communications Director
06 · Company updates
Updates from DeepHealth
Recent articles published on DeepHealth's official website.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Medical Imaging & Radiology
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.